Moderna’s (MRNA) COVID-19 was recommended for emergency use authorization (EAU) Thursday evening by an advisory committee to the U.S. Food and Drug Administration (FDA) in a majority vote, with just one abstention.
The vote brings the company one step closer to becoming the second authorized vaccine in the U.S. The advisory panel voted to allow use in adults 18 and older, including first-priority frontline health workers and nursing home residents.
For Moderna, the widely-expect…
Source link
